Pharmacological
Research
Communications,
AN EEG INVESTIGATION S. Sagratella, Laboratorio Viale
Vol. 18. No.
ON NABILONE, IN RABBITS
A. Pkzzola
A SYNTHETIC CANNABINOID,
and A.
Scotti
de Carolis
Istituto Superiore di ‘299 - 00161 Roma, Italy
dl Farmacologia, Regina Elena,
Received
653
7, 1986
in final form
24 April
Sanitl
1986
SUMMARY
In this paper, the electroencephalographic (EEG) and behavioural effects of nabilone, a derivative compound from d9-tetrahydrocannabinol (A 9-THC), are studied in comparison with those of A 8-tetrahydrocannabinol (A 8-THC) in rabbits. The results show that nabilone requires lower doses than A8-THC to elicit cortical spike-and-wave complexes, but higher doses to disrupt hippocampal theta rhythm. These data are discussed in connection with the clinical actions of nabilone in man.
INTRODUCTION Recent logical
studies
effects
degree
from
on synthetic (both
their
Nabilone
potential
beneficial
countries
for
chemotherapy Stark
euphorigenic
represents
separates
the
cannabinoids
from therapy
of
synthetic
undesiderable of
severe
Correspondence and reprints Dr. A. Scotti de Carolis Laboratorio di Farmacologia Istituto Superiore di Sanitl Viale Regina Elena, 299 00161 Roma - Italy 0031-6989/86/070653-l
O/SO3.00/0
out
the
can be separated cannabinoid
effects nausea
1979; Steele et al., --et al., and Dews (1980) found in a comparative carried
that
psychoto
some
action. the
(Herman
and chlordiazepoxide,
demonstrated
and psychotogenic)
therapeutic one
have
in mice,
rats,
and
and
compounds
is
registered
vomiting
induced
which in
by
some cancer
1980). study dogs,
between
nabi.lone,dg-THC
and Rhesus
monkeys,
clear
to:
0 1986
The Italian
Pharmacological
Society
654
Pharmacological
evidence also
of
a qualitative
between
nabilone
administration, --et
al,
that
nabilone
some anxyolytic dose
might
of
3.0
as the In
previous
were
examined
(Lipparini
rats
(-)A9-THC
and
the
EEG record,
complex
abuse
Vol. 18, No.
nabilone
man,
after
1984).
and
This
(1978,
last
1981)
relieves
d 9-THC but or
euphoria
than
suggests
nabilone
seems to
demonstrated
some symptoms
oral
d 9-THC
finding
In addition,
al.,
7, 1986
intravenous
and less
liability.
--et significantly
induced
by
by
this
natural
laboratory,
of
and
alterations
synthetic
that,
at
anxiety
as
disruption
of
the
behavioural
syndrome block
ataxia,
theta
These which of
waves
of
al.,
1973).
they
induced
the
cornel
brain
elec-
of
reflex,
were
(THCS)
In
hippocampus
EEG modifications consisted
of
tetrahydrocannabinols
1969; Willinsky --et al., --et (->A,-THC had similar effects:
spike-and-waves.
depression:
In
and Mello,
investigations
activity
voltage
between
tachycardia
Fabre
OS, it
Communications,
of depression.
trical
high
less
a lower
effects:
mg per
only
chlordiazepoxide.
Mendelson
have
feeling
not
induces
1982;
have the
and
nabilone
(Lemberger
well
similarity
Research
rabbits
and
flattening
of
and trains
of
accompanied
a mixture
of
jacksonian
by
excitement
episodes
a and
and
motor
paralysis. Willinsky theta
et
hippocampal
administration this In
put
particular
activity
observed
in
other
hallucinogenic
of
mescaline
(Longo,
(1973)
1962,
EEG change
activity
al.,
Baran
could
be
and
an
emphasis rabbits,
which
drugs, Longo,
is
such
1965),
electrical
on the as
of
also
observed
LSD,
psylocibin
the
hypothesis
the
psychodysleptic
advancing
counterpart
disruption
of
the
after and that
in man.
the
present
the
paper,
in comparison
with
those
EEG and behavioural ofd8-THC
effects
of
nabilone
were
studied
in rabbits.
METHODS Electroencephalographic preparations des.
and from
Implantation
under
ether
1962).
The
recording
(EEG) 4 chronically
of
superficial
anaesthesia animals sessions
Histological
recordings implanted
obtained rabbits
and concentric
according
acutely which
were
to
prepared started
examinations
l-2 post
were
placed
hr after mortem
10
bearing
deep
a technique
from
cortical
electrodes described
in
confirmed
rabbit electro-
was carried elsewhere
a restraining
discontinuation
acute
box
out (Longo,
for
the
of ether. the
location
of
deep
electrodes. Both
nabilone
and
A8-THC
were
dissolved
in
polyethylenglycol
300
and
Pharmacological
Research
administered solvent
Communications,
by slow
which,
intravenous
up to
0.6
655
Vol. 18, No. 7. 1986
Controls
route.
ml total
dose,
had
were
done
by administering
no influence
on the
the
EEG and beha-
vior. One drug cal
experiment
implanted
per week was carried
electrodes,
to avoid
out
tolerance
in rabbits
bearing
and cumulative
the
chroni-
doses
varying
effects.
RESULTS Nabilone from
In
6 acute
0.05-5.0
after
or
mydriasis
total and
after
the
doses
exophtalmus,
te
the
ataxically.
After of
alternated
$_8-THC
Doses
6 rabbits only
at
ranging
d8-THC theta
the
slight
reducing
and-waves; but
more
Exitations lity
disruption
mydriasis,
played
hind
EEG; doses
the
a few
Two mg/kg
(flattening)
(Fig.
1).
mydriasis, agitation
they general
and a compleshort
were
mg/kg)
first
epochs after
periods
of
in
was partially
blocked
observed
and partial
of
At
spike were
had a more
inducing
the This
with
of with
Behaviourally, excited
and dis-
pronounced
appearance dose
cornea1
1.0 mg/kg and waves
effect of
spike-
produced
similar
lasted
3-4 hr.
alterations,which alternated
to
a slight
injection.
disrupted.
behavioural
administered
produced
hour.
animals
of A8-THC
and
were
compound response
the
was markedly
movements
dose,
pronounced
exhophtalmus
10 minutes
aforementioned
the
by the
leg
rhythm
a more
(0.1-0.25
mydriasis,
decreased,
ataxia.
of
demonstrated
arousal
and arreflexia,
and ataxic
of
doses
had disappeared
was
observed hyperpnea,
periods
on a
higher
2-3 hr.
2.0 mg/kg
exophtalmus
theta
pronounced
the
Low
appeared
EEG voltage the
to
these but
the
of depression.
cortical
At
present
EEG voltage
waves
besides in
mgfkg.
were
0.1
Ten minutes
of spike-and-waves
Animals
throughout
from the
episodes
appeared.
preparations). of
0.25
frequent
a short
superimposed
with
was also
mglkg)
and a
time
observed.
showed
during
(3-5
this
complexes
and
and
doses
periods
persisted
(acute
synchronization
highest
At
and then,
excited
arreflexia
waves with
effects
arreflexia
in
a synchronization
were
in EEG voltage
were
more
theta
arreflexia
isolated
decrease
the
mg/kg appeared.
spike-and-wave
first
animals
in EEG voltage,
disruption These
mg/kg)
cornea1
0.05-0.1
cornea1
at
a slight
complete
excitation
was injected
EEG "arousal"
complete
(0.25-1.0
continuous;
of
the
EEG appeared,
Behaviourally,
decrease
of
an almost
higher
moved
nabilone
administration
blockade
desynchronized almost
preparations,
mg/kg.
A few minutes partial
rabbit
periods
of immobi-
and headnodding. After
the
highest
doses
(up
to
a total
of
10 mg/kg)
of
nabilone
like
Pharmacological
First
and third
tired
non
Second
record:
accompanied Fourth
acccompanied
nabilone
tonic seizure.
(consisting was
(1.0 (5.0
seen
under
the of
elicited
voltage
i.v.)
mg/kg,
of
cortical
cortex;
cortical
or clonic
convulsions
After
high
the
of head drop
concomitantly
alterations was 4-5 hr. The onset of drug-induced
(4 mglkg)
and flaccidity
with
The
ataxia.
effects
waves.
levels. P = posterior
hippocampus.
nor
appeared,
doses
applied.
spike-and-waves,
cortex;
= dorsal
unanaestheis
hippocampal
and hippocampal
Hipp
7, 1986
spike-and-waves
theta
F = anterior-sensorimotor
0 = optic
in the stimulus
the
elicited
at cortical
Vol. 18, No.
conditions
an acoustic
i.v.> the
Communications,
basic
arrows,
mg/kg,
record
L = left;
cortex;
neither
paralysis
At
by a flattened
sensorimotor
"grand-mal"
recorded
reduction
nabilone
R = right;
L\8-THC,
were rabbits.
by a slight
record:
Leads:
back)
records
curarized
Research
did
of both
of the duration
was shortened
the
tracing
compounds,
show a muscular
postural muscles of the of these behavioural
as the
dose
of both
drugs
increased. DISCUSSION On the the
cerebral
basis
of the
electrical
present activity
results of
rabbits
the
influence is
basically
of
nabilone similar
and A8-THC and is
charac-
on
Pharmacological
Research
10 min after
RO - I.0
Communications,
A8 THC 2 mglkg
657
Vol. 18. No. 7, 1986
i.v.
dp
RFP LPO
Fig.
2:
cally
Comparative
implanted
Similar
frontoparietal
dence 2.0
EEG effects
(6-9
Leads/
i.v.
of
See Fig.
terized
by
in
anterior
the
(lower
following
sting
of
and
mgfkg
i.v.
are of
elicited
chroni-
nabilone
at
the
(upper
same inci-
record)
and by
record).
a) appearance
of
spike-and-wave
posterior
cortex
leads
superimposed
b) disruption
of
hippocampal
theta
however,
in
is
inducing the
the
amplitude
a mixture following higher
cornea1
arreflexia
activity
of
the
at
least
complexes
EEG changes
described The
with
complexes
on a desynchronized rhythm,
c)
a generalized
active
than
in EEG voltage.
decreasing The
complexes
alterations:
spike-and-wave
A 8-THC
and A 8-THC in rabbits
1.
the
Nabilone eliciting
by 0.25
6.8-THC
electrocorticogram, decreased
nabilone
spike-and-wave
complexes/min)
mgfkg
of
electrodes.
disruption of the
are of the
potency in synthetic
5-10
, while of
more
the
2-3 times
hippocampal
A8-THC
less
effective
theta
rhythm
in than
and
in
EEG tracing.
accompanied
excitation
by a complex and depression
administration of
times appears
of
nabilone
rabbits, cannabinoid
in in
the
in respect
syndrome
qualitatively natural
eliciting
respect
behavioural
similar
THC derivatives cortical
to
&j 8-THC, to the
consito
(Table
spike-and-waves confirms
natural
the
that 1). and
higher
tetrahydrocanna-
658
Pharmacological
TABLE 1. Behavioural
and EEG effects
Research
of nabilone
Communications,
(NAB)
Vol. 18, No.
and
7, 1986
8-THC in the
rabbit.
Drug
Dose
Cornea1
mg/kg
arreflexia
0.1 11
+
0.25 II
+ +
+
1.0 11
+ +
+ +
3-5
+ +
+ +
+ +
NAB 8-THC NAB 8-THC NAB 8-THC NAB B-THC
+
-
complexes; binol
D.H.T.W.
nabilone
ataxia
by
i.v.
or
monkeys
in
our
the
previous
disruption
lower
disruptive
marjhuana
oral
Biochemical
to
+
+ +
+ +
+ +
+ +
+
=
cortical
spike-and-wave
waves.
reported more
administration muricide
(Lipparini, of
reduce
active dogs
and Dews (1980),
than
or
in
d 9-THC
fixed-ratio nabilone
in
decreasing
or in reducing
compounds
on hippocampal (Revuelta
by Stark
the the
theta
and perceptual
in
man. waves alterations
rate schedule.
hypothesis,
In
fact,
and
is
advanced 1973), test
nabilone less
of
of responding
fixed-interval
support
who
producing
the
rate
1969; Willinski --et al., --et al., theta waves can be used as a predictive
these
euphoria
in
in rats, with
and among them nabilone,
+
times
a multiple
data
+
those
under
effect
+ +
theta
results
effect
+
hippocampal
working paper
+ +
C.S.W.C.
present
in inducing
of
EEG voltage
effect;
2-4
of hippocampal
psychodysleptic
Reduction
CNS functions.
comparable
and the
In addition,
Slight
approximately
self-stimulation in Rhesus
+
several are
D.H.T.W.
+ + -
= disruption
in affecting
C.S.W.C.
exophtalmus
Absent;
Our results found
Mydriasis
+
2
Present;
Ataxia
that for
a
shows
a
effective
than
in man.
1982) indicate that et -- al., the turnover rate of GABA in
some cannabinoids, the
septum
of rats.
Pharmacological
Research
a similar
Moreover, the
hippocampus
last
effect the
connected
et
al.,
rate
anxiety
(as
(Stark
et
our
has
man
and
and
in
could
in
-et 2'al the
same
If
this
hippocampal the
these of
in
disrupcompounds
acethylcholine (Brunello
alteration
in
and
hippocampal
1969). that
animals.
a taming
and an antianxiety
effect
On the
demostrate
1979).
muscimol
literature
experimental
1978).
for
found
the
with
reduction
described
been
explain
treated
The similar
has
do not
firing
the
has
-et al L' rate of
this
rabbit
been
made
McLendon,
1978)
the
de Carolis been
the
induced
chlordiazepoxide) 1980),
al.,
in
data).
study
has
in
does
(Fabre
(Nakano
present
(Scotti
and Dews,
man
of suggest,
waves
rate
(Revuelta
authors
mention
property
nabilone
b9-THC
a reduction
in
activity
Repeated
turnover
with
hippocampus
which
1981),
electrical
in
the
acetylcholine with
theta
659
7, 1986
as these 1969,
in
of
treated
hippocampal
(Lipparini turnover Chey,
rats
neurones,
of
Vol. 18, No.
decrease of
is
cholinergic tion
Communications,
has
It
has
effect
in
septal-lesioned
at
a dosage
contrary,
a clear
nabilone been of
other
anxiolytic
anti-
shown
that rats
3.0
mg per
clinical
OS
studies
effects
of
nabilone
in man. We should
stress
nabilone.
The
after relevant
doses
reaction
(25-50
described
hand,
the
compared
,ug/kg),
after
with
the
nection, ineffective
blind
antidepressant of
anxiety.
This
feeling
that
and do not
and hilarity Pertwee,
are 1973),
marjhuana results) and 1.0
or
elicit known
or any
often
other
(Chopra hand,
relief to occurr
and Smith, in
In
particular
preliminary
they
doses
block
EEG arousal
--et
al.
anxiolitic
drug
probably
such
of anxiety. together effect
In
found the
with
occurr
to
of
unreality
previous
research the
smokers after
be
under
existing
post-smoking
in marjhuana often
con-
same authors
accentuate Moreover,
be such
this
A 9-THC
as feelings
agrees
can
administered
contrary,
EEG other
drugs,
(Fig.3). when
the
mg/kg)
anxiogenic
(1973)
On the
effects,
with On the
(0.5-1.0 of
clinically
the
same animal.
tetrahydrocannabinols
that both nabilone andA8-THC, mg/kg), are able to antagonize
drugs.
Kotin
side
finding
marjhuana
the
observed
at of
p carbolines
patients.
adverse
EEG patterns elicits,
doses
small
and psychotic-anxiogenic
abusers
On the
that
the
many similarities
in
higher
after
to depressed
prominence
increased
demonstrating
presents drugs
and several
as
of nabilone
or no impairment
after
elicited
be mentioned
the
a slight
sedative
should an
that
observed
pattern
conditions
described
features
stimulation,
pentylentetrazol,
it
double
certain with
many
spike-and-waves
as picrotoxin,
lytic
present
to vibroacoustical
pattern
and
at
EEG synchronization
anxiety (Paton
high
and
doses
in
1974). experiments at
we demonstrated
intermediate
doses
some EEG effects
of
the
slowing
of
the
(unpublished
(respectively sedative
frequency
0.2
and anxioand increase
660
Pharmacological 2 min after
PENTAMETHYLENTETRAZOL
5min
NABILONE
Research
10 mglkg
Communications,
Vol. 18, No.
7. 1986
i.v.
RF- L.F. RF
R.l?
Ls?- LO
Fig.
3:
after
Effects
of
3 mg/kg
i.v.
pentamethylentetrazol
(PTZ)
and nabilone
on the
EEG of
the
rabbit. Upper
record:
theta
hippocampal
Lower
record:
the
theta
Leads:
the
PTZ elicited
See Fig.
in
trazol)
(Sagratella
an
rabbits,
(excitant reported
and activated
by
data
anxiogenic and anxiolytic
cortical
spike-and-wave
complexes
and disrupted
diazepam
and/or
excitant may
anxiogenic
drugs)
at
drugs
the
level
of
do (picrotoxin,
the
are
support
the
hypothesis
further
and
the
anxiolytic
or anxiogenic
indebted
red
pentylente-
1985).
However, sedative
pentobarbital
studies interactions drugs activity
that
nabilone
including
other
between
nabilone
must
be carried
out
could drug or to
to Prof.
V.G.
tetrahyelucidate
of nabilone.
Longo
for
guidance
have classes
ACKNOWLEDGEMENTS The authors
the
waves.
like
effect.
drocannabinols the
elicited
and Longo,
preliminary
anxiogenic
complexes
1.
induced
nucleus These
spike-and-wave
rhythm. nabilone
hippocampal
voltage
cortical
and advice.
Pharmacological
Research
Communications,
661
Vol. 18, No. 7, 1986
REFERENCES Baran,
L.,
Longo
V.G.
Therapie,
20:
591,
(1965).
Brunello,
N.,
Cheney,
J. Pharmacol.
Exp.
Chopra,
Smith,
Arch.
G.S., Gen.
Fabre, Cur-r.
J.
Res.,
L.F.,
30:
T.S.,
Furnas,
B.,
24:
161,
Kotin,
J.,
Arch.
Gen.
Lemberger, Cancer
Einhorn,
L.,
Lipparini,
F.,
Physiol.
Behav.,
Longo,
P.
(1978).
377s
Rubin,
S.A.,
F.K.
28:
345,
(1973).
Wolen,
R.,
A.,
Nagy, Dorr,
C., R.J.,
Chester, Moon,
A.B.,
Dean,
J-C.,
T-E.
(1979).
Goodwin,
Reviews, Scotti
S.E.,
Leigh,
1295,
R.M.,
(1981). Jones,
S.D., 300:
Psychiatry,
Treatment
(1974). Stark,
L.H.,
Williams,
Post,
(1981).
D.M. 21:
J. Med.,
24,
D.M.,
MC Lendon,
Herman,
489,
J.W.
Pharmacol.,
N. Engl.
219:
MC Lendon,
Ther.
Clin.
Ther.,
Psychiatry,
L.F.,
Fabre,
D.L.
9 (Supp.
de Carolis,
De Sante, B):
A.,
17,
K.,
Rowe,
H.,
Forney,
R.,Pence,P.
(1982).
Longo,
V.G.
4: 527,(1969).
V.G.
Electroencephalographic
Atlas
Publishing
Company,
Mendelson,
J.M.,
Psychopharmacology,
for
(1962).
Mello, 83:
N.K. 351,
(1984).
Pharmacological
Research.
Amsterdam,
Elsevier
662
Pharmacological
Nakano, Clin.
S.,
Gillespie,
Pharmacol.
Paton, In:
W.D.M.,
Neuropharmacology,
18:
Life
Sci.,
Sagratella,
1841,
S.,
Scotti
Longo,
de Carolis,
J.
P.,
Pharmacol.
Steele,
N.,
Cancer
Treat.
Willinsky,
A.,
Costa,
E.
Wood P.L.
Costa,
E.
V.G. 35 (l),
la:
Lipparini,
Ther.,
Gralle,
R.J.,
Rep.,
Psychopharmacologia
(1973).
251,
F.,
(1985).
Longo,
15:
186,
(1969).
214:
124,
(1980.
V.G.
P.B.
Exp.
M.D.,
287,
(1979).
(Berl),
Dews,
pp.
Wood P.L.
D.L.,
Res.
Psychopharmacology Stark,
525,
metabolism
(1982).
Arzneim-Forsch/Drug
64:
Scotti
7, 1986
(1978).
New York,
D.L.,
Cheney,
30:
54,
pharmacology,
Academic,
Cheney,
A.V.,
Vol. 18. No.
R.G.
Chemistry,
A.V.,
Revuelta,
Communications,
L.
23 (1):
Pertwee,
R. (ed).
Revuelta,
Hollister,
Therap.,
Marjhuana:
Mechoulam,
B.,
Research
Braun, 219,
D.W.,
C.W.
(1980).
de Carolis,
(Berl.),
Young,
31:
A., 365,
Longo, (1973).
V.G.
and
clinical
effects.